Stability indicating simultaneous determination of domperidone (DP), methylparaben (MP) and propylparaben by high performance liquid chromatography (HPLC)

Journal of Pharmaceutical and Biomedical Analysis

Volumn 41, Issue 2, 2006, Pages 358-365

  Ali, Mohammed Shahid ^a   Ghori, Mohsin ^a   Khatri, Aamer Roshanali ^a  

^a Jamoom Pharmaceuticals   (Saudi Arabia)

Author keywords

Impurities; Method validation; Preservatives; Simultaneous determination; Stability indicating

Indexed keywords

AMMONIUM ACETATE; BUFFER; DOMPERIDONE; DROPERIDOL; METHANOL; METHYL PARABEN; PROPYL PARABEN; SILICON DIOXIDE; STAINLESS STEEL;

ACCURACY; ANALYTIC METHOD; AQUEOUS SOLUTION; ARTICLE; CHEMICAL BOND; DRUG DETERMINATION; DRUG PURIFICATION; DRUG QUALITY; DRUG STABILITY; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; OBSERVER VARIATION; PRIORITY JOURNAL; SEPARATION TECHNIQUE; TABLET FORMULATION; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOMPERIDONE; DOPAMINE ANTAGONISTS; DRUG STABILITY; PARABENS; PRESERVATIVES, PHARMACEUTICAL; REPRODUCIBILITY OF RESULTS; SUSPENSIONS; TABLETS;

EID: 33646526957     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2005.12.026     Document Type: Article

References (25)

1. Reynolds J.E.F. Part I, Martindale, The Extra Pharmacopoeia. 31st ed. (1996), Royal Pharmaceutical Society of Great Britain, London
2. Denyer S.P., and Baird R.M. Preservatives: Registration and Regulatory Affairs-Guide to Microbiological Control in Pharmaceuticals (1990), Ellis Horwood, West Sussex, England pp. 314-340
3. British Pharmacopoeia, The Stationary Office under License from the Controller of Her Majesty's Stationary Office, London, 2003. vol. I, pp. 66-670, and vol. III, pp. 2281-2282.
4. Amin A.S., and Ragab G.H. Analytical Sciences vol. 19 (2003), The Japan Society for Analytical Chemistry pp. 747-751
5. Al-Khamis K.I., Hagga M.E., and Al-Khamees H.A. Anal. Lett. 23 (1990) 451-460
6. Rao G.R., Kini G.R., Avadhanula A.B., and Vatsa D.K. East. Pharm. 33 (1990) 133-135
7. Rama Mohan Y., and Avadhanula A.B. Indian Drugs 35 (1998) 754-756
8. Zavitsanos A.P., MacDonald C., Bassoo E., and Gopaul D. J. Chromatogr. B: Biomed. Sci. Appl. 730 (1999) 9-24
9. Kanumula G.V., and Ramane B. Indian Drugs 37 (2000) 375-377
10. Dapkar S.S., Bhandaei N.P., and Halker U.P. Indian Drugs 37 (2000) 295-298
11. Argekar A.P., and Powar S.G. J. Planar Chromatogr. Mod. TLC. 12 (1999) 272-274
12. Kobylinska M., and Kobylinska K. J. Chromatogr. B: Biomed. Appl. 744 (2000) 207-212
13. Yamamoto K., Hagino M., Kotaki S., and Iga T. J. Chromatogr. B: Biomed. Sci. Appl. 720 (1998) 251-255
14. Dvorak J., Hajkova R., Matysova L., Novakova L., Koupparis M.A., and Solich P. J. Pharm. Biomed. Anal. 36 (November 15, 2004) 625-629
15. Novakova L., Solich P., Matysova L., and Sicha J. Anal. Bioanal. Chem. 379 (July, 2004) 781-787
16. Shabir G.A. J. Pharm. Biomed. Anal. 34 (2004) 207-213
17. Popovic G., Cakar M., and Agbaba D. J. Pharm. Biomed. Anal. 33 (2003) 131-136
18. Hajkova R., Solich P., Dvorak J., and Sicha J. J. Pharm. Biomed. Anal. 32 (2003) 921-927
19. Matysova L., Hajkova R., Sicha J., and Solich P. Anal. Bioanal. Chem. 376 (2003) 440-443
20. Kollmorgen D., and Kraut B. J. Chromatogr. B. Biomed. Sci. Appl. 707 (1998) 181-187
21. Kang S.H., and Kim H. J. Pharm. Biomed. Anal. 15 (1997) 1359-1364
22. Radus T.P., and Gyr G. J. Pharm. Sci. 72 (1983) 221-224
23. Koundourellis J.E., Malliou E.T., and Broussali T.A. J. Pharm. Biomed. Anal. 23 (2000) 469-475
24. Austin K.L., and Mather L.E. J. Pharm. Sci. 67 (1978) 1510-1511
25. ICH Haromonised Tripartite Guideline, International Conference on Harmonisation on Technical Requirements for Registration of Pharmaceuticals for Human Use, Q2A, Text on Validation of Analytical Procedures, Step 4 of the ICH process, 1994 and Q2B, Validation of Analytical Procedures: Methodology, Step 4 of the ICH process, 1996, ICH Steering Committee.